stoxline Quote Chart Rank Option Currency Glossary
Isleworth Healthcare Acquisition Corp. (ISLE)
10.01  -0.13 (-1.28%)    08-26 16:00
Open: 10.01
High: 10.02
Volume: 301,893
Pre. Close: 10.14
Low: 10.01
Market Cap: 0(M)
Technical analysis
2022-11-18 4:21:49 PM
Short term     
Mid term     
Targets 6-month :  11.69 1-year :  11.7
Resists First :  10.01 Second :  10.02
Pivot price 10.01
Supports First :  10.01 Second :  8.32
MAs MA(5) :  10.01 MA(20) :  10.01
MA(100) :  9.99 MA(250) :  9.92
MACD MACD :  0 Signal :  0
%K %D K(14,3) :  0 D(3) :  0
RSI RSI(14): 51.4
52-week High :  10.14 Low :  9.8
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ ISLE ] has closed Bollinger Bands are 100% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 44 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 10.04 - 10.09 10.09 - 10.13
Low: 9.87 - 9.94 9.94 - 9.99
Close: 9.91 - 10.02 10.02 - 10.1
Company Description

Isleworth Healthcare Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire a business in the biopharmaceutical or medical technology/device industries. The company was incorporated in 2020 and is based in Saint Petersburg, Florida.

Headline News

Fri, 26 Aug 2022
SPAC Isleworth Healthcare to dissolve after failing to complete merger - Seeking Alpha

Tue, 07 Jun 2022
Cytovia Therapeutics Appoints Luca Scavo as Chief Financial Officer and James Priour as Chief Product Officer - BioSpace

Wed, 27 Apr 2022
Cellectis Receives $20 Million Convertible Note Under Collaboration Agreement with its Partner Cytovia Therapeutics - GlobeNewswire

Wed, 27 Apr 2022
Cytovia inks SPAC merger to get natural killer cells prospects into the clinic - Fierce Biotech

Tue, 26 Apr 2022
Isleworth Healthcare Acquisition Corp. and Cytovia Therapeutics Announce Agreement for Business Combination to ... - PR Newswire

Mon, 17 Jun 2024

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Financial Services
Shell Companies
Shares Out 26 (M)
Shares Float 18 (M)
Held by Insiders 19.7 (%)
Held by Institutions 72.1 (%)
Shares Short 39 (K)
Shares Short P.Month 88 (K)
Stock Financials
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) 0 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth -60.8 %
Operating Cash Flow -1 (M)
Levered Free Cash Flow 0 (M)
Stock Valuations
PE Ratio 0
PEG Ratio 0
Price to Book value 0
Price to Sales 0
Price to Cash Flow -452.23
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android